KMDA.TA - Kamada Ltd.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
1,687.00
+20.00 (+1.20%)
At close: 5:24PM IDT
Stock chart is not supported by your current browser
Previous Close1,667.00
Open1,665.00
Bid1,686.00 x 346500
Ask1,691.00 x 57900
Day's Range1,665.00 - 1,691.00
52 Week Range1,481.00 - 2,920.00
Volume53,659
Avg. Volume41,041
Market Cap679.233M
Beta0.59
PE Ratio (TTM)9,372.22
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • MarketWatch4 days ago

    Kamada shares drop on FDA's continued concerns about therapy's safety, trial delay

    Kamada Ltd. shares dropped 4.4% in premarket trade Monday on news that the company has not been able to resolve the Food and Drug Administration's concerns about the safety of its therapy, which will delay a phase 3 clinical trial that Kamada had planned for the second half of the year. It's also possible the trial may not happen, Kamada suggested. The product, Inhaled Alpha-1 Antitrypsin, is intended to treat Alpha-1 Antitrypsin Deficiency, a genetic disorder that can lead to lung and liver disease.

  • Associated Press3 months ago

    Kamada posts 4Q profit

    On a per-share basis, the Ness Ziona, Israel-based company said it had net income of 16 cents. The biopharmaceutical posted revenue of $35.7 million in the period. For the year, the company reported net ...

  • Kamada Ltd. breached its 50 day moving average in a Bullish Manner : KMDA-IL : November 16, 2017
    Capital Cube5 months ago

    Kamada Ltd. breached its 50 day moving average in a Bullish Manner : KMDA-IL : November 16, 2017

    Categories: Europe Stock Alerts Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Kamada Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Associated Press5 months ago

    Kamada reports 3Q loss

    The Ness Ziona, Israel-based company said it had a loss of 1 cent per share. Earnings, adjusted for stock option expense, were less than 1 cent on a per-share basis. The biopharmaceutical posted revenue ...

  • Kamada Ltd. breached its 50 day moving average in a Bearish Manner : KMDA-IL : November 3, 2017
    Capital Cube6 months ago

    Kamada Ltd. breached its 50 day moving average in a Bearish Manner : KMDA-IL : November 3, 2017

    Categories: Europe Stock Alerts Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Kamada Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Kamada (KMDA) Gets FDA Approval for Rabies Vaccine
    Zacks8 months ago

    Kamada (KMDA) Gets FDA Approval for Rabies Vaccine

    Kamada Ltd. (KMDA) and partner Kedrion Biopharma and announced that FDA has approved Kedrab [rabies immune globulin (Human)] for post-exposure prophylaxis against rabies infection.

  • Associated Press9 months ago

    Kamada posts 2Q profit

    On a per-share basis, the Ness Ziona, Israel-based company said it had net income of 13 cents. Earnings, adjusted for stock option expense, came to 14 cents per share. The biopharmaceutical posted revenue ...

  • Kamada Withdraws Inhaled AAT Marketing Application in EU
    Zacks10 months ago

    Kamada Withdraws Inhaled AAT Marketing Application in EU

    Kamada Ltd.'s (KMDA) decided to withdraw the marketing authorization application (MAA) for its inhaled formulation of Alpha-1 Antitrypsin (AAT) in the EU.

  • Capital Cube10 months ago

    Kamada Ltd. – Value Analysis (TEL AVIV:KMDA) : June 16, 2017

    Categories: Europe Value Analsysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Kamada Ltd. a score of 57. Our analysis is based on comparing Kamada Ltd. with the following peers – Compugen Ltd., BioCancell Ltd., XTL Biopharmaceuticals Ltd. and RedHill Biopharma Ltd. (CGEN-IL, BICL-IL, XTLB-IL and RDHL-IL). Investment Outlook Kamada Ltd. has a fundamental score of 57 and has ... Read more (Read more...)

  • Kamada Ltd. breached its 50 day moving average in a Bearish Manner : KMDA-IL : June 15, 2017
    Capital Cube10 months ago

    Kamada Ltd. breached its 50 day moving average in a Bearish Manner : KMDA-IL : June 15, 2017

    Categories: Europe Stock Alerts Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Kamada Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Kamada (KMDA) Posts Q1 Loss Wider than Expected, Sales Miss
    Zacks11 months ago

    Kamada (KMDA) Posts Q1 Loss Wider than Expected, Sales Miss

    Kamada Ltd. (KMDA) reported adjusted loss of 11 cents in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 3 cents.

  • Associated Press11 months ago

    Kamada reports 1Q loss

    The Ness Ziona, Israel-based company said it had a loss of 11 cents per share. Losses, adjusted for stock option expense, came to 10 cents per share. The biopharmaceutical posted revenue of $11.6 million ...